Robert Hayward

3.9k total citations
21 papers, 2.1k citations indexed

About

Robert Hayward is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Robert Hayward has authored 21 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Robert Hayward's work include Melanoma and MAPK Pathways (10 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Nuclear Structure and Function (3 papers). Robert Hayward is often cited by papers focused on Melanoma and MAPK Pathways (10 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Nuclear Structure and Function (3 papers). Robert Hayward collaborates with scholars based in United Kingdom, United States and Germany. Robert Hayward's co-authors include Richard Marais, Caroline J. Springer, Catrin Pritchard, Amaya Virós, Lesley Ogilvie, Douglas Hedley, Jan Martin, Nathalie Dhomen, Maria Karasarides and Jorge S. Reis‐Filho and has published in prestigious journals such as Molecular Cell, Circulation Research and JNCI Journal of the National Cancer Institute.

In The Last Decade

Robert Hayward

21 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Hayward United Kingdom 16 1.7k 812 316 274 218 21 2.1k
Alastair J. King United States 18 1.6k 0.9× 659 0.8× 289 0.9× 223 0.8× 195 0.9× 28 2.0k
Narsis Attar United States 11 2.1k 1.2× 1.3k 1.6× 194 0.6× 297 1.1× 359 1.6× 13 2.6k
Ensar Halilovic United States 19 1.8k 1.0× 977 1.2× 373 1.2× 128 0.5× 179 0.8× 33 2.3k
Katherine G. Moss United States 15 1.2k 0.7× 666 0.8× 423 1.3× 182 0.7× 165 0.8× 17 1.9k
Andreas Gschwind Germany 9 1.6k 1.0× 1.1k 1.4× 202 0.6× 212 0.8× 67 0.3× 10 2.7k
Carla Milagre United Kingdom 6 1.1k 0.7× 712 0.9× 134 0.4× 150 0.5× 224 1.0× 8 1.4k
Mari Iida United States 30 1.5k 0.9× 1.3k 1.7× 186 0.6× 456 1.7× 60 0.3× 62 2.8k
Kakajan Komurov United States 23 1.7k 1.0× 938 1.2× 224 0.7× 294 1.1× 115 0.5× 44 2.5k
Vanessa Rodrik-Outmezguine United States 16 2.1k 1.3× 943 1.2× 164 0.5× 200 0.7× 85 0.4× 32 2.8k
Matthias Drosten Spain 22 1.4k 0.8× 777 1.0× 254 0.8× 153 0.6× 84 0.4× 43 2.0k

Countries citing papers authored by Robert Hayward

Since Specialization
Citations

This map shows the geographic impact of Robert Hayward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hayward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hayward more than expected).

Fields of papers citing papers by Robert Hayward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Hayward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hayward. The network helps show where Robert Hayward may publish in the future.

Co-authorship network of co-authors of Robert Hayward

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Hayward. A scholar is included among the top collaborators of Robert Hayward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Hayward. Robert Hayward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, Chin Yee, Mengying Wu, Sadia Ahmad, et al.. (2025). Mineral Stress Drives Loss of Heterochromatin: An Early Harbinger of Vascular Inflammaging and Calcification. Circulation Research. 136(4). 379–399. 3 indexed citations
2.
Cobb, Andrew M., et al.. (2022). Filamentous nuclear actin regulation of PML NBs during the DNA damage response is deregulated by prelamin A. Cell Death and Disease. 13(12). 1042–1042. 11 indexed citations
3.
Cobb, Andrew M., Robert Hayward, Sadia Ahmad, et al.. (2020). Runx2 (Runt-Related Transcription Factor 2) Links the DNA Damage Response to Osteogenic Reprogramming and Apoptosis of Vascular Smooth Muscle Cells. Arteriosclerosis Thrombosis and Vascular Biology. 41(4). 1339–1357. 39 indexed citations
4.
Frustaci, Andrea, Romina Verardo, Cristina Chimenti, et al.. (2019). Prelamin A mediates myocardial inflammation in dilated and HIV-associated cardiomyopathies. JCI Insight. 4(22). 36 indexed citations
5.
Chow, Wing Ying, Ieva Goldberga, David G. Reid, et al.. (2018). Essential but sparse collagen hydroxylysyl post-translational modifications detected by DNP NMR. Chemical Communications. 54(89). 12570–12573. 13 indexed citations
6.
Li, Chen, Bin Zhou, Ian Holt, et al.. (2017). Novel nesprin-1 mutations associated with dilated cardiomyopathy cause nuclear envelope disruption and defects in myogenesis. Human Molecular Genetics. 26(12). 2258–2276. 77 indexed citations
7.
Martin, Matthew J., Robert Hayward, Amaya Virós, & Richard Marais. (2012). Metformin Accelerates the Growth of BRAFV600E-Driven Melanoma by Upregulating VEGF-A. Cancer Discovery. 2(4). 344–355. 116 indexed citations
8.
Smith, Michael P., Jennifer Ferguson, Imanol Arozarena, et al.. (2012). Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma. JNCI Journal of the National Cancer Institute. 105(1). 33–46. 82 indexed citations
9.
Packer, Leisl, Sareena Rana, Robert Hayward, et al.. (2011). Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia. Cancer Cell. 20(6). 715–727. 97 indexed citations
10.
Arozarena, Imanol, Berta Sanchez‐Laorden, Leisl Packer, et al.. (2011). Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A. Cancer Cell. 19(1). 45–57. 168 indexed citations
11.
Milagre, Carla, Nathalie Dhomen, Felipe C. Geyer, et al.. (2010). A Mouse Model of Melanoma Driven by Oncogenic KRAS. Cancer Research. 70(13). 5549–5557. 60 indexed citations
12.
Kamata, Tamihiro, Jahan Hussain, Susan Giblett, et al.. (2010). BRAF Inactivation Drives Aneuploidy by Deregulating CRAF. Cancer Research. 70(21). 8475–8486. 38 indexed citations
13.
Whittaker, Steven R., Richard Kirk, Robert Hayward, et al.. (2010). Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies. Science Translational Medicine. 2(35). 35ra41–35ra41. 118 indexed citations
14.
Dhomen, Nathalie, Silvy da Rocha Dias, Robert Hayward, et al.. (2009). Inducible expression ofV600EBraf using tyrosinase-driven Cre recombinase results in embryonic lethality. Pigment Cell & Melanoma Research. 23(1). 112–120. 18 indexed citations
15.
Dhomen, Nathalie, Jorge S. Reis‐Filho, Silvy da Rocha Dias, et al.. (2009). Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice. Cancer Cell. 15(4). 294–303. 408 indexed citations
16.
Hussain, Jahan, Susan Giblett, Robert Hayward, et al.. (2008). CRAF Autophosphorylation of Serine 621 Is Required to Prevent Its Proteasome-Mediated Degradation. Molecular Cell. 31(6). 862–872. 67 indexed citations
17.
Gray‐Schopfer, Vanessa C., Maria Karasarides, Robert Hayward, & Richard Marais. (2007). Tumor Necrosis Factor-α Blocks Apoptosis in Melanoma Cells when BRAF Signaling Is Inhibited. Cancer Research. 67(1). 122–129. 96 indexed citations
18.
Dumaz, Nicolas, Robert Hayward, Jan Martin, et al.. (2006). In Melanoma, RAS Mutations Are Accompanied by Switching Signaling from BRAF to CRAF and Disrupted Cyclic AMP Signaling. Cancer Research. 66(19). 9483–9491. 241 indexed citations
19.
Newbatt, Yvette, Robert Hayward, Steven R. Whittaker, et al.. (2006). Identification of Inhibitors of the Kinase Activity of Oncogenic V600EBRAF in an Enzyme Cascade High-Throughput Screen. SLAS DISCOVERY. 11(2). 145–154. 11 indexed citations
20.
Karasarides, Maria, Antonio Chiloeches, Robert Hayward, et al.. (2004). B-RAF is a therapeutic target in melanoma. Oncogene. 23(37). 6292–6298. 360 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alastair J. King Breakdown of academic impact, for papers by Narsis Attar Breakdown of academic impact, for papers by Ensar Halilovic Breakdown of academic impact, for papers by Katherine G. Moss Breakdown of academic impact, for papers by Andreas Gschwind Breakdown of academic impact, for papers by Carla Milagre Breakdown of academic impact, for papers by Mari Iida Breakdown of academic impact, for papers by Kakajan Komurov Breakdown of academic impact, for papers by Vanessa Rodrik-Outmezguine Breakdown of academic impact, for papers by Matthias Drosten
Rankless by CCL
2026